DIAGNOS Announces a New Partner in Cambodia

Biotech Investing

DIAGNOS announced the addition of a new medical partner, Garuda Health Services, to cover the country of Cambodia.

DIAGNOS (TSXV:ADK; OTCQB:DGNOF) announced the addition of a new medical partner, Garuda Health Services, to cover the country of Cambodia.
As quoted in the press release:

Garuda Health Services (GHS) first customer will be Royal Phnom Penh Hospital. A new screening service will be offered to their clientele at their annual physical exam. The service is scheduled to be launched in late fall of this year and should cover 22,400 patients under their care. DIAGNOS’ CARA solution will provide automatic detection and classification of Diabetic Retinopathy disease. Detection of anomalies for AMD (Age Macular Degeneration) is also planned to be available. In early 2018, CARA Cardio is scheduled to be added as a new screening service for cardio vascular diseases.
“In adding eye screening with retina anomalies detection, we are increasing the number of health points to better determine the global health of our patients. This will significantly help us to prevent disease evolution and take early action. As DIAGNOS is developing new algorithms to detect more illness, we will be ready to use them.

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×